Emily Stephenson - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Emily Stephenson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Emily Stephenson

Emily Stephenson

Verified

Deputy Managing Editor, The Assembly

Journalist Type

-

Seniority Positions

Industries

Medium Formats

Content

Total articles 2264

  • Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alpha.

    By Kirsty Hodgson, Gary Reynolds, Emily Stephenson, Joseph Inns| bioRxiv@ AbstractCYLD cutaneous syndrome (CCS) skin tumors develop from puberty onwards, can number in the hundreds and progressively grow over time. CCS patients lack medical therapies and require repeated surgery to control tumor burden. CYLD loss of heterozygosity (LOH) drives tumor growth, and CCS tumors have previously been shown to demonstrate increased canonical NF-κB and Wnt signalling.

    By Kirsty Hodgson, Gary Reynolds, Emily Stephenson, Joseph Inns · bioRxiv

    Feb. 03, 2025

  • N.C. Lawmaker Says "Emergency is Still in Place" After Helene

    By Emily Stephenson| The Assembly Verified The state legislature last week unanimously passed a $273 million package aimed at providing relief to Western North Carolina after the devastation caused by Hurricane Helene. Lawmakers said it’s only the first round of disaster spending, with more expected as they determine what’s needed. In addition to funds for state agencies, the legislation gives schools more flexibility over their calendars and allows 25 western counties to adjust polling sites and make other election-related changes.

    By Emily Stephenson · The Assembly

    Oct. 13, 2024

  • Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alpha.

    By Kirsty Hodgson, Gary Reynolds, Emily Stephenson, Joseph Inns| bioRxiv@ AbstractCYLD cutaneous syndrome (CCS) skin tumors develop from puberty onwards, can number in the hundreds and progressively grow over time. CCS patients lack medical therapies and require repeated surgery to control tumor burden. CYLD loss of heterozygosity (LOH) drives tumor growth, and CCS tumors have previously been shown to demonstrate increased canonical NF-κB and Wnt signalling.

    By Kirsty Hodgson, Gary Reynolds, Emily Stephenson, Joseph Inns · bioRxiv

    Feb. 03, 2025

As seen in

Company Info

The Assembly

A digital magazine for stories that aren't being told - and for those that deserve a deeper look.

Raleigh, North Carolina, United States